FIELD: biotechnology, helminthology. SUBSTANCE: vaccine is a conjugate of immunostimulating carrier with protective antigen. Protective antigen: protein isolated from connective tissues and showing hyalurosno-lyase activity, its molecular mass is 63000 Da, isoelectric point - at 5.7. Mass ratio of antigen and carrier = 1:(1-10). Vaccine can contain adjuvant, for example, polyaxidonium, muramyldipeptide, aluminium hydroxide. Vaccine is used for prophylaxis and treatment of different helminthiasis forms in human and animals. EFFECT: enhanced effectiveness of vaccine. 3 cl
Title | Year | Author | Number |
---|---|---|---|
PREPARATION FOR TREATMENT OF CONNECTIVE TISSUE PATHOLOGICAL STATE | 1997 |
|
RU2112542C1 |
VACCINE AGAINST INFLUENZA VIRUS AND METHOD OF ITS PREPARING | 2000 |
|
RU2164148C1 |
CONJUGATE FOR IMMUNISATION AND VACCINATION AND METHOD FOR IMPROVING IMMUNOGENICITY | 2008 |
|
RU2378015C2 |
VACCINE AGAINST INFECTIONS INDUCED BY OPPORTUNISTIC PATHOGENS | 2001 |
|
RU2204412C2 |
VACCINE AGAINST TUBERCULOSIS | 1999 |
|
RU2153354C1 |
IMMUNOMODULATING DRUG | 1996 |
|
RU2112543C1 |
METHOD OF PREPARING SUBSTANCE SHOWING IMMUNOSTIMULATING, ANTIVIRAL AND ANTIBACTERIAL ACTIVITY, SUBSTANCE OBTAINED BY THIS METHOD AND PHARMACEUTICAL COMPOSITION BASED ON THEREOF | 2001 |
|
RU2195308C1 |
ALLERGOTROPIN FOR TREATING POLLINOSIS AND METHOD FOR TREATING POLLINOSIS | 2001 |
|
RU2205661C2 |
BROAD-SPECTRUM M2 PROTEIN ECTODOMAIN AVIAN INFLUENZA TYPE A VACCINE | 2014 |
|
RU2571944C1 |
RECOMBINANT TRIVALENT INFLUENZA VACCINE | 2012 |
|
RU2485973C1 |
Authors
Dates
1997-11-10—Published
1996-08-02—Filed